Shalini Sharp - 20 Jan 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Director
Signature
/s/Reena R. Desai, Attorney-inFact
Issuer symbol
N/A
Transactions as of
20 Jan 2023
Net transactions value
$0
Form type
4
Filing time
24 Jan 2023, 15:03:15 UTC
Previous filing
14 Jun 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +4,444 +89% $0.000000 9,414 20 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Non Qualified Stock Option (right to buy) Award $0 +7,520 $0.000000 7,520 20 Jan 2023 Common Stock 7,520 $45.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
F2 The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.